A patient with amyopathic dermatomyositis associated with fatal rapidly progressive interstitial pneumonitis resistant to therapy is described. Pathologic examination of a transbronchial lung biopsy specimen showed diffuse alveolar damage and nonspecific interstitial pneumonia-organizing pneumonia-like findings. Bronchoalveolar lavage fluid contained many CD8+ lymphocytes, considered to be cytotoxic T cells. Analysis of bronchoalveolar lavage fluid in this case may provide prognostically and pathogenetically important information.
Fudman EJ, Schnitzer TJ. Dermatomyositis without creatine kinase elevation. A poor prognostic sign. Am J Med. 1986; 80:329-332.
2.
Fernandes L, Goodwill CJ. Dermatomyositis without apparent myositis, complicated by fibrosing alveolitis. J R Soc Med. 1979;72:777-779.
3.
Takizawa H, Shiga J, Moroi Y, Miyachi S, Nishiwaki M, Miyamoto T.Interstitial lung disease in dermatomyositis: clinicopathological study. J Rheumatol. 1987;14:102-107.
4.
Nawata Y, Kurasawa K, Takabayashi K, et al.Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine. J Rheumatol. 1999;26:1527-1533.
5.
Gondo H, Minematsu T, Harada M, et al.Cytomegalovirus (CMV) antigenaemia for rapid diagnosis and monitoring of CMV-associated disease after bone marrow transplantation. Br J Haematol. 1994;86:130-137.
6.
Honda J, Okubo Y, Imamura Y, Kusaba M, Saruwatari N, Oizumi K.Flow cytometric detection of cytomegalovirus antigen in peripheral blood cells after bone marrow transplantation. Br J Haematol. 1997;99:415-417.
7.
Greene NB, Solinger AM, Baughman RP. Patients with collagen vascular disease and dyspnea: The value of gallium scanning and bronchoalveolar lavage in predicting response to steroid therapy and clinical outcome. Chest. 1987;91:698-703.
8.
Gruhn WB, Diaz-Buxo JA. Cyclosporine treatment of steroid resistant interstitial pneumonitis associated with dermatomyositis/polymyositis. J Rheumatol. 1987;14:1045-1047.
9.
Katzenstein AL, Fiorelli RF. Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol. 1994;18:136-147.
10.
Sauty A, Rochat T, Schoch OD, et al.Pulmonary fibrosis with predominant CD8 lymphocytic alveolitis and anti-Jo-1 antibodies. Eur Respir J. 1997;10:2907-2912.
11.
Kourakata H, Takada T, Suzuki E, et al.Flowcytometric analysis of bronchoalveolar lavage fluid cells in polymyositis/dermatomyositis with interstitial pneumonia. Respirology. 1999;4:223-228.
12.
Kanai Y, Tokano Y, Tsuda H, Hashimoto H, Okumura K, Hirose S.HLA-DP positive T cells in patients with polymyositis/dermatomyositis. J Rheumatol. 1993;20:77-79.
13.
Orosz CG, Roopenian DC, Widmer MB, Bach FH. Analysis of cloned T cell function. II. Differential blockade of various cloned T-cell functions by cyclosporine. Transplantation. 1983;36:706-711.
14.
Ejstrup L.Severe dermatomyositis treated with cyclosporine A. Ann Rheum Dis. 1986;45:612-613.
15.
Tazelaar HD, Viggiano RW, Pickersgill J, Colby TV. Interstitial lung disease in polymyositis and dermatomyositis. Clinical features and prognosis as correlated with histologic findings. Am Rev Respir Dis. 1990;141:727-733.
16.
Kurasawa K, Nawata Y, Takabayashi K, et al.Activation of pulmonary T cells in corticosteroid-resistant and -sensitive interstitial pneumonitis in dermatomyositis/polymyositis. Clin Exp Immunol. 2002;129:541-548.
